On ECHEMI

Nanjing Xinbell Pharmaceutical Technology Co., Ltd.

China
Favorite Supplier
 545 people visit

Company Profile

Nanjing Xinbell Pharmaceutical Technology Co., Ltd. is a company specialized in developing, manufacturing and marketing of Active Pharmaceutical ingredients (APIs) and their intermediates. The company also offers Custom Synthesis services. Xinbell has established firmed co-operations with several university and R&D centers. Xinbell provides high quality products, complete documentation and other outstanding supports to the customers. Customers are based in Europe, India, Korea, Japan and other Southeast Asia.

VIEW MORE VIEW LESS

Product List

Product Name Synonyms CAS No. Grate/Content Operate

(1R,2S)-2-(3,4-Difluorophenyl)cyclopropanaminium (2R)-hydroxy(phenyl)ethanoate

Benzeneacetic acid,α-hydroxy-,(αR)-(1R,2S)-compd. with 2-(3,4-difluorophenyl)cyclopropanamine (1:1);Benzeneacetic acid,α-hydroxy-,(αR)-,compd. with (1R,2S)-2-(3,4-difluorophenyl)cyclopropanamine (1:1)
376608-71-8 Inquiry

(3R,4R)-3,4-Dimethyl-4-(3-hydroxyphenyl)piperidine

Phenol,3-[(3R,4R)-3,4-dimethyl-4-piperidinyl]-;Phenol,3-(3,4-dimethyl-4-piperidinyl)-,(3R-cis)-;3-[(3R,4R)-3,4-Dimethyl-4-piperidinyl]phenol;(+)-(3R,4R)-Dimethyl-4-(3-hydroxyphenyl)piperidine;(+)-(3R,4R)-3,4-Dimethyl-4-(3-hydroxyphenyl)piperidine;(3R,4R)-3,4-Dimethyl-4-(3-hydroxyphenyl)piperidine;(3R,4R)-3-(3,4-Dimethyl-4-piperidinyl)phenol
119193-19-0 Inquiry

(3R,4R)-N,4-Dimethyl-1-(phenylmethyl)-3-piperidinamine hydrochloride

3-Piperidinamine,N,4-dimethyl-1-(phenylmethyl)-,hydrochloride (1:2),(3R,4R)-
1062580-52-2 Inquiry

(3R,4S)-4-[4-(Benzyloxy)phenyl]-1-(4-fluorophenyl)-3-[3-(4-fluorophenyl)-3-oxopropyl] azetidin-2-one

(3R,4S)-4-[4-(Benzyloxy)phenyl]-1-(4-fluorophenyl)-3-[3-(4-fluorophenyl)-3-oxopropyl]azetidin-2-one;E6:synthesis of trans-1-(4-fluorophenyl)-3-[3-oxo-3-(4-fluorophenyl)propyl;2-Azetidinone, 1-(4-fluorophenyl)-3-[3-(4-fluorophenyl)-3-oxopropyl]-4-[4-(phenylMethoxy)phenyl]-, (3R,4S)-;3R,4S)-4-[4-(Benzyloxy)phenyl]-1-(4-fluorophenyl)-3-[3-(4-fluorophenyl)-3-oxopr;ETMB-06;EzetiMibe interdiate;(3R,4S)-4-(4-(Benzyloxy)phenyl)-1-(4-fluorophenyl)-3-(3-(4-fluorophenyl)-3-oxopropyl)azetidin-2-o;EZ-ETK
190595-65-4 Inquiry

(4S)-3-[(5S)-5-(4-Fluorophenyl)-5-hydroxypentanoyl]-4-phenyloxazolidin-2-one

(5R)-1-[(5S)-5-(4-Fluorophenyl)-5-hydroxy-1-oxopen
1027552-46-0 Inquiry

(alphaS,betaR)-beta-(2,5-Difluorophenyl)-beta-hydroxy-alpha-methyl-1H-1,2,4 -triazole-1-butanenitrile

Isavuconazole interMediate 7;(αS,βR)-β-(2,5-Difluorophenyl)-β-hydroxy-α-Methyl-1H-1,2,4-triazole-1-butanenitrile;241479-74-3 (2S,3R)-3-(2,5-difluorophenyl)-3-hydroxy-2-Methyl-4-(1H-1,2,4-triazol-1-yl)butanenitrile;(alphaS,betaR)-beta-(2,5-Difluorophenyl)-beta-hydroxy-alpha-methyl-1H-1,2,4-triazole-1-butanenitrile;Isavuconazole intermediate;(2S,3R)-3-(2,5-Difluorophenyl)-3-hydroxy-2-Methyl-1H-1,2,4-triazole-1-butanenitrile;4-triazole-1-butanenitrile;5-Difluorophenyl)-β-hydroxy-α-Methyl-1H-1
241479-74-3 Inquiry

(R)-Dihydro-4-propyl-2(3H)-furanone

brivaracetam intermediate 1;Brivaracetam Intermediate;(R)-4-propyl-dihydro-furan-2-one;(R)-Dihydro-4-propyl-2(3H)-furanone;(R)-4-propyldihydrofuran-2(3H)-one;(+)-(R)-4-propyl-4,5-dihydrofuran-2(3H)-one
63095-51-2 Inquiry

(S)-2-(((3R,4R)-4-(3-Hydroxyphenyl)-3,4-dimethylpiperidin-1-yl)methyl) -3-phenylpropanoic acid methyl ester hydrochloride

1-Piperidinepropanoic acid,4-(3-hydroxyphenyl)-3,4-dimethyl-α-(phenylmethyl)-,methyl ester,hydrochloride (1:1),(αS,3R,4R)-;1-Piperidinepropanoic acid,4-(3-hydroxyphenyl)-3,4-dimethyl-α-(phenylmethyl)-,methyl ester,hydrochloride,[3R-[1(S*),3α,4α]]-;1-Piperidinepropanoic acid,4-(3-hydroxyphenyl)-3,4-dimethyl-α-(phenylmethyl)-,methyl ester,hydrochloride,(αS,3R,4R)-;(3R,4R)-1-((2S)-2-Benzyl-3-methoxy-3-oxopropyl)-4-(3-hydroxyphenyl)-3,4-dimethylpiperidine hydrochloride
170098-28-9 Inquiry

1-Cyclopropyl-4-isothiocyanatonaphthalene

1-cyclopropyl-4-isothiocyanatonaphthalene;Naphthalene, 1-cyclopropyl-4-isothiocyanato-;1-cyclopropyl-4-isothiocyanato Naphthalene;1-cyclopropyl-4-isothiocyanato-naphthalene;Lesinurad Impurity 17;SCHEMBL248662;BCP11539;CS-D0226;ZINC40435313;AKOS028108229
878671-95-5 Inquiry

1H-Benzimidazole-2-butanoic acid, 1-methyl-5-nitro-, ethyl ester

ethyl 4-(1-methyl-5-nitro-1H-benzo[d]imidazol-2-yl)butanoate;1-Methyl-5-nitro-1H-benzimidazole-2-butanoic acid ethyl ester;1-Methyl-5-nitro-1H-benzimidazole-2-butanoic Acid Ethyl Ester-d3;(5-Nitro-1-Methyl-1H-benzo[d]iMidazol-2-yl)butanoic acid ethyl ester;BendaMustine Nitro Ethyl Ester IMpurity;ethyl 4-(1-Methyl-5-nitro-1H-1,3-benzodiazol-2-yl)butanoate;Ethyl 4-(1-methyl-5-nitro-1H-benzo[d]imidazol-2-yl);ethyl 4-(1-methyl-5-nitrobenzimidazol-2-yl)butanoate
3543-72-4 Inquiry

1H-Benzimidazole-2-butanoic acid, 5-amino-1-methyl-, ethyl ester

5-AMINO-1-METHYL-1H-BENZIMIDAZOLE-2-BUTANOIC ACID ETHYL ESTER;Ethyl-4-(5-aMino-1-Methy-1H-benzo[d] iMidazol-2-yl)butanoate;1-Methyl-5-amino-1H-benzimidazole-2-butanoic acid ethyl ester;4-(5-Amino-1-methyl-1H-benzoimidazol-2-yl)-butyric acidethylester;5-amino-1-methyl-2-Benzimidazolebutyric acid ethyl ester;5-AMino-1-Methyl-;4-[5-AMino-1-MethylbenziMidazol-2-yl]butanoic acid ethyl ester;1-Methyl-5-aMino-1H-benziMidazole-2-butanoic acid ethyl este
3543-73-5 Inquiry

1H-Benzimidazole-7-carboxylic acid, 1-[[2'-(2,5-dihydro-5-oxo-1,2,4-oxadiazol-3-yl)[1,1'-biphenyl]-4-yl]methyl]-2-ethoxy

1H-Benzimidazole-7-carboxylic acid,1-[[2′-(2,5-dihydro-5-oxo-1,2,4-oxadiazol-3-yl)[1,1′-biphenyl]-4-yl]methyl]-2-ethoxy-;1-[[2′-(2,5-Dihydro-5-oxo-1,2,4-oxadiazol-3-yl)[1,1′-biphenyl]-4-yl]methyl]-2-ethoxy-1H-benzimidazole-7-carboxylic acid;TAK 536;2-Ethoxy-1-[[2′-(4,5-dihydro-5-oxo-1,2,4-oxadiazol-3-yl)biphenyl-4-yl]methyl]benzimidazole-7-carboxylic acid;Azilsartan;2-Ethoxy-1-[[2′-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)biphenyl-4-yl]methyl]-1H-benzimidazole-7-carboxylic acid;Azilva;2-Ethoxy-3-[[4-[2-(5-oxo-2H-1,2,4-oxadiazol-3-yl)phenyl]phenyl]methyl]benzimidazole-4-carboxylic acid;2-Ethoxy-1-([4-[2-(5-oxo-2,5-dihydro-1,2,4-oxadiazol-3-yl)phenyl]phenyl]methyl)-1H-1,3-benzodiazole-7-carboxylic acid
147403-03-0 Inquiry

1H-Dibenz[2,3:6,7]oxepino[4,5-c]pyrrol-1-one, 11-chloro-2,3,3a,12b-tetrahydro-2-methyl-, (3aR,12bR)-rel-

trans-(+/-)-11-Chloro-2,3,3a,12b-tetrahydro-2-methyl-1H-dibenz[2,3:6,7]oxepino[4,5-c]pyrrol-1-one;trans-11-chloro-2-methyl-2,3,3a,12b-tetrahydro-1H-dibenzo[2,3:6,7]oxepino[4,5-c]pyrrol-1-one;trans-11-Chloro-2,3,3a,12b-tetrahydro-2-methyl-1H-dibenz-[2,3:6,7]-oxepino-[4,5-c]-pyrrol-1-one;trans-11-chloro-2,3,3a,12b-tetrahydro-2-methyl-1H-dibenz[2,3:6,7]oxepino[4,5-c]pyrrol-1-one;SCHEMBL3152476;BCP10015;CS-M0229;EX-A4129;ZINC95080665;CS-13054
129385-59-7 Inquiry

2,4-Thiazolidinedione, 5-[[4-[2-(5-ethyl-2-pyridinyl)ethoxy]phenyl]methylene]-

2,4-Thiazolidinedione,5-[[4-[2-(5-ethyl-2-pyridinyl)ethoxy]phenyl]methylene]-;5-[[4-[2-(5-Ethyl-2-pyridinyl)ethoxy]phenyl]methylene]-2,4-thiazolidinedione;5-[4-[2-(5-Ethylpyridin-2-yl)ethoxy]benzylidene]thiazolidine-2,4-dione;5-[4-[2-(5-Ethyl-2-pyridinyl)ethoxy]benzylidene]-1,3-thiazolidine-2,4-dione;5-[4-[2-(5-Ethyl-2-pyridyl)ethoxy]benzylidene]thiazolidine-2,4-dione
144809-28-9 Inquiry

2-chloro-1-(2,5-difluorophenyl)ethanone

Ethanone,2-chloro-1-(2,5-difluorophenyl)-;2-Chloro-1-(2,5-difluorophenyl)ethanone;2-Chloro-1-(2,5-difluorophenyl)ethan-1-one
60468-36-2 Inquiry

2-fluoro-5-(4-oxo-3,4-dihydro-phthalazin-1-yl methyl)benzoic acid

Benzonitrile,5-[(3,4-dihydro-4-oxo-1-phthalazinyl)methyl]-2-fluoro-;5-[(3,4-Dihydro-4-oxo-1-phthalazinyl)methyl]-2-fluorobenzonitrile;2-Fluoro-5-[(4-oxo-3,4-dihydrophthalazin-1-yl)methyl]benzonitrile;2-Fluoro-5-[(4-oxo-3H-phthalazin-1-yl)methyl]benzonitrile
1021298-68-9 Inquiry

2-Oxazolidinone, 3-[(2R,5S)-5-(4-fluorophenyl)-2-[(S)-[(4-fluorophenyl)amino] [4-[(trimethylsilyl)oxy]phenyl]methyl]-1-oxo-5-[(trimethylsilyl)oxy]pentyl]-4-phenyl-, (4S)-

3-[(2R,5S)-5-(4-FLUOROPHENYL)-2-[(S)-[(4-FLUOROPHENYL(AMINO)]] [4-[TRIMETHYLSILYL]-OXY]PHENYL]METHYL]-1-OXO-5-[(TRIMETHYLSILY)-OXY]PENTYL]-4-PHENYL-(4S)-2-OXAZOLIDINONE;2-OXAZOLIDINONE, 3-[(2R,5S)-5-(4-FLUOROPHENYL)-2-[(S)-[(4-FLUOROPHENYL)AMINO][4-[(TRIMETHYLSILYL)OXY]PHENYL]METHYL]-1-OXO-5-[(TRIMETHYLSILYL)OXY]PENTYL]-4-PHENYL-, (4S)-;3-[(2r,5s)-5-(4-Fluorophenyl)-2-[(S)-[(4-Fluorophenyl( Amino)]][4-[Trimethylsilyl]-Oxy]Phenyl]Methyl]-1-Oxo-5-[(Trimethylsilyl)-Oxy]Pentyl]-4-Phenyl-(4s)-2-Oxazolidinone;3-[(2R,5S)-5-(4-fluorophenyl)-2-{(S)-[4-fluorophenyl]Amino}[4-(trimethylsily)-oxy]pentyl]methyl-1-2oxo-5-(trimethylsilyl)-oxo]penyl]-4-phenyl-(4S)-2-oxazolidinone;3-[(2R,5S)-5-(4-FLUOROPHENYL)-2-[(S)-[(4-FLUOROPHENYL( AMINO)]] [4-[TRIMETHYLSILYL]-OXY]PHENYL]METHYL]-1-OXO-5-[(TRIMETHYLSILY) -OXY]PENTYL]-4-PHENYL-(4S)- 2-OXAZOLIDINONE(INTERMEDIATE OF EZETIMIBE);INTERMEDIATE OF EZETIMIBE
272778-12-8 Inquiry

2-[(5-Chloropyridin-2-yl)amino]-2-oxoacetic acid ethyl ester monohydrochloride

Edoxaban iMpurities 3
1243308-37-3 Inquiry

2-[[(3aR,4S,6R,6aS)-6-Aminotetrahydro-2,2-dimethyl-4H-cyclopenta-1,3-dioxol-4-yl]oxy] -ethanol (2R,3R)-2,3-dihydroxybutanedioate

2-((3aR,4S,6R,6aS)-6-amino-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-yloxy)ethanol L-tataric acid;2-[[(3aR,4S,6R,6aS)-6-Aminotetrahydro-2,2-dimethyl-4H-cyclopenta-1,3-dioxol-4-yl]oxy]-ethanol (2R,3R)-2,3-dihydroxybutanedioate;Ticagrelor InterMediate 2;2-[[(3aR, 4S, 6R, 6aS)6-aMinotetrahydro-2,2-diMethyl-4-H-cyclopenta-1,3-dioxol-4-yl]oxy]-(2R,3R)-2,3-dihydroxybutanedioateethanol;2-((3aR,4R,6R,6aR)-6-Amino-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-yloxy)ethanol L-tataric acid;2-((3aR,4S,6R,6aS)-6-amino-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-yloxy)ethanol L-tat;2-(((3aR,4S,6R,6aS)-6-amino-2,2-dimethyltetrahydro-4H-cyclopenta[d][1,3]dioxol-4-yl)oxy)ethan-1-ol (2R,3R)-2,3-dihydroxysuccinate;Ethanol, 2-[[(3aR,4S,6R,6aS)-6-aminotetrahydro-2,2-dimethyl-4H-cyclopenta-1,3-dioxol-4-yl]oxy]-, (2R,3R)-2,3-dihydroxybutanedioate (1:1) (salt)
376608-65-0 Inquiry

3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl) -3-oxopropanenitrile

1-Piperidinepropanenitrile,4-methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-β-oxo-,(3R,4R)-;3-Piperidinamine,1-(cyanoacetyl)-4-methyl-N-methyl-N-1H-pyrrolo[2,3-d]pyrimidin-4-yl-,(3R,4R)-;(3R,4R)-4-Methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-β-oxo-1-piperidinepropanenitrile;CP 690550;Tofacitinib;2097815-04-6
477600-75-2 Inquiry

CONTACT INFORMATION

Send an inquiry

Product Name:
Quantity:
Shipment Term:

China

  • China
  • Albania
  • Algeria
  • Angola
  • Anguilla
  • Antigua and Barbuda
  • Argentina
  • Armenia
  • Aruba
  • Australia
  • Austria
  • Azerbaijan
  • Bahamas
  • Bahrain
  • Bangladesh
  • Barbados
  • Belgium
  • Belize
  • Benin
  • Bermuda
  • Bhutan
  • Bolivia
  • Bosnia and Herzegovina
  • Botswana
  • Brazil
  • Brunei
  • Bulgaria
  • Burkina-faso
  • Burundi
  • Cameroon
  • Canada
  • Cape Verde
  • Cayman Islands
  • Central African
  • Chad
  • Chile
  • Colombia
  • Comoros
  • Cook Is.
  • Costa Rica
  • Croatia
  • Curacao
  • Cyprus
  • Czech
  • Democratic Republic of the Congo
  • Denmark
  • Djibouti
  • Dominica
  • Ecuador
  • Egypt
  • El Salvador
  • Equatorial Guinea
  • Eritrea
  • Estonia
  • Ethiopia
  • Faroe Islands
  • Fiji
  • Finland
  • France
  • French Guiana
  • French Polynesia
  • Gabon
  • Gambia
  • Georgia
  • Germany
  • Ghana
  • Gibraltar
  • Greece
  • Greenland
  • Grenada
  • Guadeloupe
  • Guam
  • Guatemala
  • Guinea
  • Guinea-Bissau
  • Guyana
  • Haiti
  • Honduras
  • Hongkong, China
  • Hungary
  • Iceland
  • India
  • Indonesia
  • Ireland
  • Israel
  • Italy
  • Ivory Coast
  • Jamaica
  • Japan
  • Jordan
  • Kampuchea (Cambodia )
  • Kazakstan
  • Kenya
  • Kiribati
  • Kosovo
  • Kuwait
  • Kyrgyzstan
  • Laos
  • Latvia
  • Lebanon
  • Lesotho
  • Liberia
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • Macao, China
  • Madagascar
  • Malawi
  • Malaysia
  • Maldives
  • Mali
  • Malta
  • Marshall Island
  • Martinique
  • Mauritania
  • Mauritius
  • Mayotte
  • Mexico
  • Micronesia
  • Moldova
  • Monaco
  • Mongolia
  • Montenegro
  • Montserrat
  • Morocco
  • Mozambique
  • Myanmar
  • Namibia
  • Nauru
  • Nepal
  • Netherlands
  • Netherlands Antilles
  • New Caledonia
  • New Zealand
  • Nicaragua
  • Niger
  • Nigeria
  • Norfolk Island
  • North Macedonia
  • Norway
  • Oman
  • Pakistan
  • Palau
  • Palestine
  • Panama
  • Papua New Cuinea
  • Paraguay
  • Peru
  • Philippines
  • Poland
  • Portugal
  • Puerto Rico
  • Qatar
  • Republic of the Congo
  • Reunion Island
  • Romania
  • Russia
  • Rwanda
  • Saint Kitts and Nevis
  • Saint Martin
  • Saint Vincent and the Grenadines
  • Samoa
  • San Marino
  • Sao Tome and Principe
  • Saudi Arabia
  • Senegal
  • Serbia
  • Seychelles
  • Sierra Leone
  • Singapore
  • Slovakia
  • Slovenia
  • Solomon Is
  • Somali
  • South Africa
  • South Korea
  • South Sudan
  • Spain
  • Sri Lanka
  • St.Lucia
  • Suriname
  • Swaziland
  • Sweden
  • Switzerland
  • Taiwan, China
  • Tajikstan
  • Tanzania
  • Thailand
  • The British Virgin Islands
  • The Dominican Republic
  • The Islamic Republic of Mauritania
  • The Islands of st pierre and miquelon
  • The Turks and Caicos Islands
  • Timor-Leste
  • Togo
  • Tonga
  • Trinidad and Tobago
  • Tunisia
  • Turkey
  • Turkmenistan
  • Tuvalu
  • Uganda
  • United Arab Emirates
  • United Kingdom
  • United States
  • Uruguay
  • Uzbekistan
  • Vanuatu
  • Vatican
  • Vietnam
  • Wallis et Futuna
  • Western Sahara
  • Yemen
  • Zaire
  • Zambia
  • Zimbabwe
  • Afghanistan
  • Belarus
  • Cuba
  • Iran
  • Iraq
  • Libya
  • North Korea
  • Sudan
  • Syria
  • Ukraine
  • Venezuela
Message:
0/2000
Accept quotations from other qualified suppliers on ECHEMI.com

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.